Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV

Weight and body mass index (BMI) change was assessed among women after switch to integrase inhibitors (INSTIs) and/or tenofovir alafenamide (TAF). From 2006 to 2019, 1,458 women living with HIV enrolled in the Women's Interagency HIV Study and on antiretroviral therapy (ART) with ≥1 study visit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Res Hum Retroviruses
Main Authors: Lahiri, Cecile D., Xu, Yanxun, Wang, Kunbo, Alvarez, Jessica A., Sheth, Anandi N., O'Halloran, Jane, Spence, Amanda B., Tien, Phyllis, Gustafson, Deborah R., Milam, Joel, Fischl, Margaret A., Konkle-Parker, Deborah, Adimora, Adaora A., Sharma, Anjali, Weber, Kathleen M., Ofotokun, Igho, Rubin, Leah H.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc., publishers 2021
Assuntos:
Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8213005/
https://ncbi.nlm.nih.gov/pubmed/33231474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2020.0197
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados